MjLink Cannabis Business News and Press
The Mississippi Legislature is making changes to its medical cannabis legalization proposal after reaching an agreement on legislation last month.
The bill is an attempt to restore the will of Mississippi voters after the state’s Supreme Court overturned a voter-approved medical cannabis ballot measure earlier this year.
Gov. Tate Reeves has said he will call a special session for cannabis policy reform if he and lawmakers can agree on the legislation.
The revised proposal would allow larger cultivation facilities, restructure the excise tax on medical cannabis products and limit the Mississippi Department of Agriculture’s role in overseeing the program, according to an AP News report.
Mississippi Agriculture and Commerce Secretary Andy Gipson previously said during an interview with SuperTalk Mississippi that he does not want medical cannabis regulated under his department.
New legislation in Luxembourg would legalize adult-use cannabis.
Under the bill, adults 18 and older would be allowed to grow up to four plants at home for personal use, making Luxembourg the first European country to legalize the cultivation and use of cannabis, according to a CNN report.
The legislation also allows the trading of cannabis seeds, the news outlet reported, and does not limit the THC level.
The bill would also lessen the current penalties for cannabis possession, according to CNN. Fines would be reduced from between $291 and $2910 to between $29 and $581 for possession offenses, according to CNN, although public consumption will remain illegal.
The push for cannabis legalization is aimed at cracking down on the illicit market and drug-related crime, CNN reported. The bill has the support of the government coalition, according to the news outlet, but it is currently awaiting a vote in parliament.
CHICAGO--(BUSINESS WIRE)--PRESS RELEASE--Cresco Labs, a vertically integrated multistate operator and wholesaler of branded cannabis products, announced today its “Summer of Social Justice” nationwide initiative raised over $250,000 for social justice-focused community organizations and supported the expungement process for over 1,000 individuals with cannabis-related criminal records.
In June, a trailer was released for “The Sentence of Michael Thompson,” a documentary short film part of Cresco Labs’ “Summer of Social Justice” initiative. The film will be released in 2022.
The “Summer of Social Justice” initiative that launched on June 19th—the 50th anniversary of the War on Drugs—was supported by Cresco Labs, its Sunnyside retail brand and its flagship cannabis brand, Cresco. The initiative encompassed the support of community expungement events and Know Your Rights workshops, a documentary short film on the War on Drugs’ impact on the sentencing of Michael Thompson and financial contributions from the company and its third-party vendors. The initiative also helped amplify the ongoing restorative justice, community business incubator and education and workforce development programming facilitated by Cresco Labs’ SEED (Social Equity & Educational Development) initiative.
“Through our ‘Summer of Social Justice’ initiative, we affirm our commitment to social equity as a company core value,” said Charlie Bachtell, CEO of Cresco Labs. “As the United States moves to decriminalize cannabis and the industry continues to grow, it is critical that businesses use their platforms and resources to help restore communities and create opportunities for the BIPOC people and their families impacted by the War on Drugs. We appreciate the passion of our partners, customers and employees who lent their voices, time, expertise and money to efforts that are building and uplifting the communities we operate in. Cresco Labs is committed to continuing initiatives like the ‘Summer of Social Justice’ that will help the cannabis industry to continue to develop into a responsible and respectable one.”
Chima Enyia, Cresco Labs’ Executive Vice President of SEED, added, “It was a privilege to lead a nationwide expungement initiative that supported the restoration of rights and agency for over one thousand people and collaborate with every business unit across the organization to deploy meaningful programming that raised broad awareness of social equity and engaged our customers and partners to act. There are still over 40,000 people imprisoned with cannabis charges across the country, and for these people, their families and their communities the War on Drugs continues. As our inaugural ‘Summer of Social Justice’ initiative ends, we’ll continue demonstrating our commitment and responsibility to historically marginalized people, businesses and communities, as well as encouraging our peers and customers to continue supporting social justice-focused community organizations.”
'Summer of Social Justice' Initiative Highlights
In total, the “Summer of Social Justice” initiative raised more than $250,000.Cresco Labs’ third-party vendors donated over $150,000, which was contributed to various community organizations around the nation for their ongoing social justice work.A portion of proceeds from the wholesale of Cresco branded products, Sunnyside in-store fundraising and anonymous matching contributions totaled over $100,000, which went toward the Cannabis Justice Initiative, a component of the Return to Freedom Project from the National Association for Criminal Defense Lawyers, to provide free legal resources to individuals impacted by the War on Drugs.Collaborated with eight community-based organizations—National Diversity & Inclusion Cannabis Alliance, Institute of Community Justice, PA Medical Marijuana Education Center, National Expungement Works, Center for Community Alternatives, Legal Aid Society of NYC, Black and Brown Cannabis Guild and Social Change—in 10 states to support over 25 expungement events and Know Your Rights information sessions.Served over 1,000 people at expungement events and Know Your Rights workshops with rap sheet obtainment, expungement eligibility review, record expungement legal support and legal rights education.Cresco Labs employees committed hundreds of hours of support to provide education, legal, marketing and fundraising services to social justice-focused community organizations.Released the trailer for “The Sentence of Michael Thompson,” a documentary short film about the story of Michigan’s longest-serving non-violent offender. Granted clemency this past January, Thompson was serving a 60-year sentence in Muskegon Correctional Facility in Michigan for selling 3 pounds of cannabis to a police informant in 1994. The documentary will be released in 2022.Launched a microsite on the Cresco brand website that encouraged people and businesses to act on criminal justice reform through sharing personal stories, signing Last Prisoner Project’s (LPP) Time to Heal petition or sending a letter of support to people currently in prison for cannabis offenses.Contributed to the collection of more than 4,000 signatures, surpassing LPP’s goal, through a Sunnyside in store petition and the Cresco brand microsite. LPP’s Time to Heal campaign calls on President Biden to advance criminal justice reform by granting clemency for the tens of thousands of people incarcerated with federal cannabis convictions.]]>San Bernardino County's "Operation Hammer Strike" struck again, with law enforcement seizing over 60,000 illicit cannabis plants in weeks seven and eight of the investigation.
In week seven from Oct. 11-17, the San Bernardino County Sheriff's Department (SBSD) Marijuana Enforcement Team (MET) and other deputies served 23 search warrants for various locations across nine cities in San Bernardino County, after receiving "numerous complaints" about illegal outdoor and indoor cannabis cultivations within these areas, according to a press release from SBSD headquarters.
Sheriff's personnel arrested 15 suspects and eradicated 159 greenhouses, one THC extraction lab and three electrical bypasses, the release states. Investigators also seized "20,031 marijuana plants, 3,596 pounds of processed marijuana, three guns, 8 grams of concentrated marijuana and 8.9 grams of methamphetamine."
Twenty-three search warrants were issued in week eight of the operation, which took place Oct. 18-24, according to a press release from SBSD headquarters.
Law enforcement personnel arrested 38 suspects and liquidated 160 greenhouses and six indoor grow facilities throughout the locations.
According to the release, investigators also found over 40,000 illicit cannabis plants, more than 5,000 pounds of processed cannabis, nearly $120,000 in cash and seven guns.
The fate of 23 pre-approved companies seeking five medical cannabis dispensary licenses in Rhode Island will be in the hands of a blindfolded former FBI agent on Oct. 29.
Russell Griffiths, an economic and policy analyst with the Rhode Island Department of Business Regulation, will have his eyes covered when he picks five numbered balls from a transparent tumbler borrowed from Twin River Casino at 10 a.m. Friday, according to the department’s Office of Cannabis Regulation (OCR). A livestream of the lottery will be available via Zoom.
The licensing lottery was originally scheduled for early August but was delayed after one of four rejected applicants brought forth an administrative appeal. Overall, the state received 45 applications from 28 companies in December. Four companies did not qualify for the lottery.
Instead of further delay, OCR is moving forward with 23 pre-approved companies that have submitted 37 applications for the right to open a dispensary in five zones across the state. A lottery to select a dispensary for a sixth zone in the Newport area will not be held because of the administrative appeal, The Associated Press reported.
The luck of the draw for the 23 companies participating in this week’s lottery ranges from two to 11 applications in the five zones. Zone 3’s license, for instance, will be awarded to either Green Wave CC Inc. or Rhode Island Compassion Center Inc., while 11 companies are in the running for Zone 4’s license. One ball will be randomly picked from each zone.
Rhode Island currently has three licensed medical cannabis dispensaries, including the Thomas C. Slater Compassion Center in Providence, the Greenleaf Compassion Center in Portsmouth and the Summit Medical Compassion Center in Warwick.
]]>The New York State Department of Labor (NYSDL) recently issued guidance prohibiting New York employers from drug screening most workers for cannabis.
The guidance states that the use of cannabis is legal under the Marijuana Regulation and Taxation Act (MRTA), which was signed into law by former New York Gov. Andrew Cuomo in June.
Under the NYSDL guidance, "employers are prohibited from discriminating against employees based on the employee's use of cannabis outside of the workplace, outside of work hours, and without the use of the employer's equipment or property.” However, employers can still ban the use of cannabis during "work hours" or the possession of the substance at work.
Marissa Mastroianni, an attorney from the Cannabis Law Group at Cole Schotz, told Cannabis Business Times and Cannabis Dispensary that the NYSDL’s guidance is "precedent-setting."
"This is really the first state to ban altogether testing for cannabis use unless in very limited circumstances," Mastroianni said. "This is definitely big news for any employer that has employees in New York state because you don't just have to be a New York employer to be covered by this."
The new law applies to anyone employed in the state of New York. Whether someone is an out-of-state employer that has an office in New York, or if they have remote workers in the state, they must comply with the new guidance, she said.
You never know what’s waiting around the corner for your in the cannabis business. Just a few weeks ago, at Cannabis Conference 2021, Dr. Sue Sisley provided a riveting keynote speech about her success in suing the DEA and the DOJ—eliminating the 52-year-old government-enforced research monopoly and eventually acquiring a Schedule I research license to cultivate cannabis flower for FDA-approved clinical trials. She was off to the races.
“Then I had this revelation, I said, ‘Oh my goodness, I'm selling weed to the DEA!’” she said at the show. “This is so historic!”
Then, earlier this week, Bank of America closed the Scottsdale Research Institute’s accounts—essentially shutting down her work.
Now, it remains to be seen how this fallout transforms Sisley’s goals. We’ll be following along. But it just goes to show that banking challenges abound, and potentially upending disasters lurk around this industry.
Let us know: What’s the biggest challenge your team is facing right now?
We’ve rounded up some of the key cannabis headlines from the week right here.
The list for pesticides that can be used on cannabis without being a violation of the Pesticide Applicators' Act has been updated. Please note the following products have been added:
Athena IPMCutsGrowth SpurtJet-Ag 5%RhapsodyTransistorTo view the updated list, click here for a pdf or click here for an Excel form. For questions regarding this change, contact Jolynn Morris at (303) 869-9060 or email [email protected].
The Colorado Department of Agriculture (CDA) is currently reviewing pesticide labels upon request and maintaining a list of products whose label it has reviewed that it believes could be used on marijuana without violating 35-10-117(1)(i), as long as the applicator follows the label directions.
Please be sure to review the list; pesticide products may be removed from the allowed products list if the registrant has not renewed their pesticide product with the department. Use of unregistered pesticides on cannabis would be a violation of the Pesticide Applicators' Act.
Stay Informed
A new poll shows that the majority of Americans now support cannabis regulation.
A nationwide study commissioned by SICPA North America revealed that 80% Americans support a program to make it easier to detect legal vs. illegal cannabis products, according to a press release.
SICPA, a provider of regulatory compliance solutions, conducted the poll online in collaboration with The Harris Poll and surveyed over 2,000 U.S. adults.
The findings indicate nationwide support for securely labeling cannabis products to confirm their legitimacy and safety, according to the press release.
According to the poll, 83% of Americans think states where cannabis is legal should require licensed cannabis producers to use secure labels that cannot be counterfeited to ensure accurate potency and consumer safety.
Ohio Rep. Jamie Callender has introduced a new bill to legalize adult-use cannabis in the Buckeye State as advocates work on their own legalization proposal.
The legislation would legalize the cultivation, processing, distribution and sale of cannabis for adults 21 and older, according to an Ohio News Time report.
In July, Reps. Casey Weinstein and Terrance Upchurch introduced their own cannabis legalization bill, which includes provisions covering decriminalization, a cannabis excise tax, commerce and licensing, and medical cannabis.
The Coalition to Regulate Marijuana Like Alcohol is also working on an adult-use legalization proposal; the group re-launched efforts this summer to get its proposed adult-use cannabis law in front of the Ohio Legislature. The Ohio Ballot Board certified the group’s initiated statute as a single issue Aug. 30, clearing the way for the Coalition to Regulate Marijuana Like Alcohol to gather the more than 130,000 required signatures to present the proposed legislation to lawmakers.
New York’s Cannabis Control Board (CCB) held its second meeting Oct. 21, where regulators announced proposed rules that would allow home grow for medical cannabis patients, as well as provisions to expunge more than 200,000 past cannabis-related offenses.
Under the proposed regulations, registered medical cannabis patients and caregivers could grow up to three immature and three mature plants per individual, or up to six immature and six mature plants per household, according to a local WBFO report.
New York has roughly 150,695 patients enrolled in its medical cannabis program, according to the Times Union. Without a legal home grow option, these patients have been required to purchase products from one of the state’s 10 licensed medical cannabis businesses, the news outlet reported.
On the criminal justice side, the more than 200,000 records of past cannabis convictions are currently being withheld from criminal background checks, according to WBFO, and the offenses would be expunged under the new CCB rules.
The proposed regulations will now undergo a 60-day public comment period, WBFO reported, and could be amended based on the feedback received.
On July 12, California Gov. Gavin Newsom signed legislation to combine the state's three cannabis regulatory agencies into one, creating the California Department of Cannabis Control (DCC), which celebrated 100 days as a new state department yesterday.
RELATED: California Governor Signs Legislation to Establish Department of Cannabis Control
Throughout the 100-day period, the DCC has made significant changes to better California's cannabis industry, support cannabis businesses and improve the state's regulatory framework, according to a recent press release from the DCC.
Some of the improvements and accomplishments the DCC has had throughout the 100-day period are listed in the press release as follows:
Launched $100 million local grant program, informed by meetings and input from 17 eligible jurisdictions, to support the transition of businesses into annual licensure by funding completion of local and environmental reviewsConsolidated three sets of regulations into one, reducing duplicative and conflicting cannabis business regulations, aligning core application requirements and allowing business-to-business trade samplesToured more than 20 licensed cannabis businesses representing all license types, with direct engagement between the licensees and newly-appointed DCC leadership teamTransitioned hundreds of provisional licenses to annual licenses, recently issuing the 3,000th annual licenseReviewed 140 standard operating procedures and 100 method validations submitted by applicants for testing laboratory licenseServed or assisted on 118 search warrants targeting unlicensed activity resulting in seizure or destruction of more than 71,751 pounds of cannabis and cannabis product worth nearly $121.6 million, eradication of 273,326 plants, and seizure of $655,000 in cash and 14 firearms; this also includes focused efforts in Mendocino County, Siskiyou County and the Southern California high desert region to support enforcement against water diversions Completed ISO 17025 pre-assessment for California's state-run cannabis testing laboratoryMerged organizational structure of the three programs into one, creating singular points of contact for stakeholders forging DCC's strategic plan and unified culture, and developing the organization's mission, vision and valuesNamed permanent and transitionary leadership teamRelaunched cannabis.ca.gov with expanded state cannabis information"We've made meaningful early progress as a new department, but this is only the beginning," said Nicole Elliott, DCC director, in the press release. "DCC will continue to direct significant effort to building a safe, sustainable and equitable cannabis market, including by engaging with all stakeholders, improving access to licensure, and streamlining and simplifying the regulatory framework."
Looking Ahead
Following the recent discovery that more than half of the registered hemp fields tested in Southern Oregon are actually growing THC-rich cannabis, one county in the area has declared a state of emergency, as reported by Associated Press.
Jackson County officials report law enforcement officers and regulators are overwhelmed by the number of illegal cannabis farms in the area and have asked the governor and state legislature for help.
AP reports illegal cannabis farms have been found to steal water, creating a greater urgency in the Western U.S. where droughts have become more persistent.
Officials in Jackson County report many of these illicit growing operations are posing as legal hemp farms.
In July, The Oregon Liquor and Cannabis Commission (OLCC) adopted temporary rules to allow the agency to work with the Oregon Department of Agriculture (ODA) to test registered hemp fields across the state to determine if the farmers are growing legal hemp (containing less than 0.3% THC) or illegal cannabis (containing more than 0.3% THC). Farms with plants containing more than 5% THC were considered cannabis operations.
During the inspections, dubbed “Operation Table Rock,” inspectors found that out of test results available for 212 farms, 114 had tested as cannabis.
Read more about the investigation here.]]>The U.S. Postal Service (USPS) amended its "Hazardous, Restricted, and Perishable Mail" policy Oct. 20 to prohibit the mailing of any vaping product.
The USPS developed its final rule on the mailability of vapes to be in compliance with the Preventing Online Sales of E-Cigarettes to Children Act (POSECCA) signed into law by former President Donald Trump last year, which regulates the sale and delivery of electronic delivery systems (ENDS)
According to the bill text, POSECCA strictly:
Although the final rule specifically bans ENDS—making the legislation appear to be specific to nicotine products—Congress uses the term to describe all vaping products, making cannabis, CBD and hemp products fit in the category of what lawmakers banned, according to the final rule.
The Public Pushes Back
The USPS received over 15,700 public comments on the proposed regulations, according to the final rule. Some feedback included commenters requesting that the agency provide an alternative method for regulating these products or making certain exceptions, as well as asking for an extension of the effective date.
As Rhode Island lawmakers get closer to reaching an agreement on an adult-use cannabis legalization proposal, the conversation is turning toward what kind of regulatory body will oversee the marketplace, according to a local WPRI report.
State Sen. Josh Miller, who sponsored an adult-use cannabis bill that cleared the Rhode Island Senate in June, told the news outlet that lawmakers are debating whether to establish a new cannabis commission to regulate the adult-use market, or whether the adult-use industry should fall under the authority of the Rhode Island Department of Business Regulation, which oversees the state’s medical cannabis program.
Lawmakers have already reached agreements on other provisions in the legislation, WPRI reported, such as licensing 30-40 adult-use cannabis dispensaries instead of the 150 retailers outlined in Miller’s original bill.
Miller told the news outlet that lawmakers have also agreed on expungement provisions, as well as a social equity component to the business licensing process.
The Rhode Island Legislature and governor’s office have been working on the adult-use cannabis legalization proposal for months, according to WPRI, after Miller's legislation stalled at the end of last year’s legislative session.
A new budget bill could allow Washington, D.C. to launch legal cannabis sales.
The Harris Rider, which has been included in budget legislation for the past seven years, has blocked the city government from regulating adult-use sales, but that language has been omitted from this year’s Senate appropriations bill, according to Forbes.
Washington, D.C. voters legalized the personal cultivation and possession of cannabis in 2014, the news outlet reported, but Congress has since used budget legislation to bar the city government from legalizing commercial adult-use sales.
RELATED: D.C. Gears Up for Adult-Use Cannabis Sales
The Harris Rider, named for its author, Maryland Republican Rep. Andy Harris, prohibits D.C. from legalizing and regulating adult-use cannabis, although the city launched legal medical cannabis sales in 2013, according to Forbes.
BOCA RATON, Florida, Oct. 21, 2021 - PRESS RELEASE - Jushi Holdings Inc., a vertically integrated multi-state cannabis operator, announced that it has entered into definitive documentation in respect of a U.S. $100 million Senior Secured Credit Facility (the acquisition facility) from a portfolio company of SunStream Bancorp Inc. (Sunstream), a joint venture sponsored by Sundial Growers Inc. Jushi intends to initially draw U.S. $40.0 million from the acquisition facility to fund the cash portion of the recently completed acquisition of Nature’s Remedy of Massachusetts Inc. (Nature’s Remedy) and certain of its affiliates. Additionally, the company will consider borrowing future amounts under the acquisition facility for potential strategic expansion opportunities in its core and developing markets.
"Securing non-dilutive funding from Sunstream strengthens our balance sheet and positions us to aggressively pursue our national growth plans," said Jim Cacioppo, Jushi chief executive officer, chairman and founder. "This increased financial flexibility will allow us to continue our ongoing expansion efforts in existing markets such as Nevada, Illinois, Ohio and California, and pursue new, potential target markets such as New Jersey, Maryland, and other high-growth regions. We remain focused on identifying strategic opportunities to bolster our operations across the supply chain, with a view to fostering long-term value for our shareholders."
After being drawn, loans issued under the acquisition facility will bear an interest rate of 9.5% per annum, payable quarterly, and mature five years from the closing date. Jushi will be able to make draws under the facility for 18 months and will have a two-year interest-only period before partial amortization begins quarterly. Jushi also holds the ability to increase the total commitment of the acquisition facility by an aggregate amount of up to $25 million, subject to certain conditions of the agreement. The acquisition facility is secured by a first lien over certain company assets and on a pari passu basis with current senior indebtedness on existing assets that are collateralized under Jushi's current senior debt facility.
Further details on the credit facility can be found in Jushi's documents filed under the company's profile on SEDAR at www.sedar.com.
]]>DENVER, Oct. 21, 2021 /CNW/ - BellRock Brands Inc., a cannabis multi-state house of brands, today announced that the company has entered into a licensing agreement with Curio Wellness to manufacture and distribute its iconic Mary's Medicinals line to cannabis retailers in Maryland. Curio Wellness, Maryland's market-leading health and wellness company, already manufactures and distributes BellRock's Dixie line of cannabis-infused products. BellRock anticipates that Mary's products, including its Transdermal Patches, Transdermal Gel Pen, Transdermal Compounds and Muscle Freeze, will become available through Curio Wellness during the first quarter of 2022.
Founded in 2013 with the goal of transforming how people view and utilize cannabis, Mary's Medicinals is known for its innovative delivery methods and robust library of intellectual property including a U.S. patent for its acclaimed transdermal technology. In August 2021, BDSA named Mary's Medicinals as the Best-Selling Cannabis Brand in the Topicals Category for 1H 2021.
"We are very pleased to announce an exclusive partnership with Curio Wellness in Maryland," said BellRock President Brian Jansen. "Curio Wellness' history perfectly aligns with the mission and values of Mary's Medicinals. Both companies share an unrelenting commitment to quality, science, and innovation. By unifying Mary's and Dixie under one roof in Maryland, we will benefit from resulting company synergies and expand distribution in the state."
Curio Wellness will manufacture the Mary's Medicinals line in its new, 34,000-square-foot, state-of-the-art processing facility in Timonium, Md. Among the largest in the country, Curio Wellness' facilities are the only in the state whose products meet cGMP standards, the same quality standard set for the world's leading pharmaceutical companies to ensure that consumer products meet the most stringent quality and efficacy guidelines.
"Mary's Medicinals has always been on our radar, lauded for its solid reputation and patient-first mentality. The brand has stood the test of time and has continued to innovate to reimagine wellness for patients," said Michael Bronfein, CEO of Curio Wellness. "We look forward to adding Mary's to the Curio Wellness family and further enhancing and diversifying our offerings to better meet patients' needs."
]]>A cannabis researcher who has fought against the U.S. Drug Enforcement Administration (DEA) has a new battle to fight after Bank of America closed her institute’s account.
Dr. Sue Sisley, president of Scottsdale Research Institute (SRI), has been conducting FDA-approved trials to evaluate cannabis as a medical treatment for military veterans and terminally ill patients. She took to Twitter Oct. 15 to share that Bank of America closed the institute’s account, potentially threatening the future of her study.
“Bank of America closes down account of Federally-licensed cannabis researcher,” Sisley wrote. “SRI conducts FDA approved controlled trials evaluating cannabis as medicine for treating pain/PTSD in military veterans & terminally ill patients this TRAGICALLY shuts down our research.”
RELATED: Cannabis Conference 2021 Keynote: 'Sue‘n The DEA: The Story of a Cannabis Research Breakthrough'
The bank notified Sisley in an Oct. 12 letter that it would be closing the account, according to a Law360 report. Bank of America directed SRI to stop writing checks and to cancel any recurring payments within three weeks.
The Texas Department of State Health Services (DSHS) has added a statement to its website declaring that delta-8 THC is illegal under state law.
“Texas Health and Safety Code Chapter 443 (HSC 443), established by House Bill 1325 (86th Legislature), allows Consumable Hemp Products in Texas that do not exceed 0.3% Delta-9 tetrahydrocannabinol (THC),” the website reads. “All other forms of THC, including Delta-8 in any concentration and Delta-9 exceeding 0.3%, are considered Schedule I controlled substances.”
Until now, businesses have sold products containing the compound under a grey area of the law, according to the Dallas Observer.
Gov. Greg Abbott signed H.B. 1325 into law in 2019, after the 2018 Farm Bill federally legalized industrial hemp, to legalize the cultivation of hemp that contains less than 0.3% delta-9 THC in Texas. The law did not specifically address delta-8, however, and manufacturers have since ramped up the production of delta-8 products under the assumption that it is legal in Texas, the Dallas Observer reported.
Now that the DSHS has clarified its stance and declared delta-8 a Schedule I controlled substance, this grey area of the law has been eliminated.
